trial

iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders

NCTId NCT05899348
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 69 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2025-07-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
69 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2023-10-01
Primary completion
2025-07-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
iTEST

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
The University of Texas at DallasCollaborator
University of MiamiCollaborator

Sites

2 total
La Jolla, United StatesRichardson, United States

Facts & assertions

4 sourced
Enrollment
69
Phase
NA
Primary Completion Date
2025-07-01
Status
COMPLETED
relationships
The graph out of here
drug
iTEST
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
The University of Texas at Dallas
company
University of Miami
company
indication
Schizo Affective Disorder
indication
Psychotic Disorders
indication
Psychotic Disorders
indication